Methotrexate bioavailability after oral and intramuscular administration in children

The Journal of Pediatrics

Volumn 110, Issue 5, 1987, Pages 788-792

  Teresi, Mary E ^a,b   Crom, William R ^a,b   Choi, Kyung E ^a,b   Mirro, Joseph ^a,b   Evans, William E ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADMINISTRATION; BIOAVAILABILITY; BLOOD AND HEMOPOIETIC SYSTEM; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; DRUG ADMINISTRATION; DRUG ANALYSIS; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DOSE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; THERAPY;

ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; CHILD; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; KINETICS; LEUKEMIA, LYMPHOCYTIC; METHOTREXATE;

EID: 0023195465     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(87)80025-2     Document Type: Article

References (24)

1. Comparison of intravenous and oral high-dose methotrexate in the treatment of solid tumors
2. The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man
3. High-dose oral methotrexate
4. Effect of route of administration and effusions on methotrexate pharmacokinetics
5. Pharmacokinetics of oral methotrexate in children
6. Pharmacokinetics of low dose methotrexate (LD-MTX) in rheumatoid arthritis (RA)
7. The bioavailability of oral intermediate-dose methotrexate
8. Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukemia
9. Small intestinal transit time affects methotrexate absorption in children with acute lymphoblastic leukemia
10. Absorption of methotrexate under standardized conditions in children with acute lymphoblastic leukemia
11. Methotrexate absorption in children with acute lymphoblastic leukemia
12. Pharmacokinetics of low-dose methotrexate in children receiving maintenance therapy for acute lymphoblastic leukemia
13. Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia: identification of a relation between concentration and effect
14. Evaluation of a fluorescence polarization immunoassay procedure for quantitation of methotrexate
15. Clinical pharmacology of intermediate-dose oral methotrexate
16. Bioavailability of methotrexate tablets
17. Bioavailability of methotrexate: implications for clinical use
18. Enhancement of methotrexate absorption by subdivision of dose
19. Can food influence the absorption of methotrexate in children with acute lymphocytic leukemia?
20. Methotrexate and folate content of erythrocytes in patients receiving oral vs intramuscular therapy with mtthotrexate
21. Serum profiles of methotrexate after its administration in children with acute lymphoblastic leukemia
22. Low-dose methotrexate kinetics in arthritis
23. Comparison of serum concentrations of methotrexate after various routes of administration
24. Methotrexate: bioavailability and pharmacokinetics